Full-Service Global Support for COVID-19 Studies

  • Post author:
  • Post category:

Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response. We address emerging pandemics, epidemics and outbreaks with expertise that supports health and research efforts globally. We are experienced in addressing the complex aspects of infectious diseases — from infection prevention and control to clinical research on diagnostics, vaccines and treatment.

Continue ReadingFull-Service Global Support for COVID-19 Studies

Following the Epidemiology in Infectious Disease Trials: A COVID-19 Case Study

  • Post author:
  • Post category:

With infectious disease outbreaks, expanding immunity from previous infection and vaccination efforts can change where the outbreak is occurring. In this video, Loice Magaria, Clinical Research Project Manager at FHI Clinical discusses strategies implemented to address changing epidemiology in a study investigating COVID-19 treatments.

Continue ReadingFollowing the Epidemiology in Infectious Disease Trials: A COVID-19 Case Study

Follow the Epi: Finding TB-Prevalent Populations to Guide TB Vaccine Protocol Design

In this plenary discussion, experts in infectious diseases discuss how real-world epidemiology data, site capacity data and biosurveillance methodology could help identify TB-prevalent populations during protocol design, helping to ensure an adequate sample for TB vaccine development.

Continue ReadingFollow the Epi: Finding TB-Prevalent Populations to Guide TB Vaccine Protocol Design

Rapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment

  • Post author:
  • Post category:

Targeted geographic areas for the development of an antimalarial drug by Novartis included malaria-endemic regions in Africa and Asia, and Novartis requested assistance identifying and assessing potential clinical sites for their planned clinical trial. Our team conducted 38 rapid, in-depth, 2.5-day site feasibility assessments in the 18 countries.

Continue ReadingRapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment

Our Clinical Trial Experience With Chikungunya Virus

  • Post author:
  • Post category:

CHIKV outbreaks have occurred in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. It was found for the first time in the Americas on islands in the Caribbean in 2013 and has spread throughout most of the Americas. It has since been identified in over 60 countries in Asia, Africa, Europe and the Americas. No commercially available vaccine to prevent or medicine to treat CHIKV infection is currently available.

Continue ReadingOur Clinical Trial Experience With Chikungunya Virus